The global vitamin & mineral supplements is an ever-flourishing market. The growth attributes to the increased demand for supplements as a tool to treat various medical conditions and stay healthy.
Besides, initiatives of consumers and public health agencies promote the inclusion of vitamin & mineral supplements to diets, aiming to reduce and prevent chronic diseases and improve healthy life spans.
Moreover, the penetration of self-monitoring devices, web, and mobile apps escalates market growth through direct-to-consumer genetic testing and easy remote access to medical consultations. According to Market Research Future (MRFR), the global vitamin & mineral supplements market is expected to reach USD 108.14 BN by 2025, registering 6.70% CAGR during the review period.
Additionally, the emergence of customization of medicines and advances in manufacturing techniques push the market growth, bringing new opportunities. Also, healthy lifestyle trends among consumers to prevent diseases and thus to avoid expensive healthcare costs and extend healthy life spans generate substantial growth opportunities.
Furthermore, the recent COVID 19 outbreak is estimated to increase market demand, presenting the need to boost immunity. On the other hand, stringent regulatory frames and side effects associated with the overconsumption of these supplements are the significant factors projected to restrict the market growth.
Get Free Sample Copy of “Vitamin & Mineral Supplements Market” @
https://www.marketresearchfuture.com/sample_request/8816
Global Vitamins Market – Segments
The report is segmented into four dynamics;
By Type : Vitamin (Vitamin B, C, D, E, Multivitamins, others) and Mineral (Calcium, Magnesium, Iron, Zinc, Multi-Minerals, others), and Blends.
By End User : Men, Women, and Unisex.
By Distribution Channel: Store-Based (Supermarkets & Hypermarkets, Specialty Stores, others) and Non-Store-Based.
By Regions : North America, Asia Pacific, Europe, and the Rest-of-the-World.
Global Vitamins Market – Regional Analysis
Asia Pacific dominates the global vitamin & mineral supplements market. The largest market share attributes to the increasing demand for nutritional products and focuses on preventive healthcare over curative solutions. The region offers enormous growth opportunities to manufacturers and suppliers. Also, the region has long been attracting international investors and industry players with its raw material advantage and cost-competitive logistics.
The region is estimated to witness higher growth due to the growing demand from the health supplements market, especially in developing countries like India and China. Markets in India and China are substantially larger in the region. China is expected to retain its dominance in the region throughout the forecast period, reaching USD 23,175.5 million by 2025, with 7.94% CAGR during the forecast period. India is projected to grow at 7.92% during the forecast period.
North America stands second in the global vitamin & mineral supplements market. The region accounted for 34.50% share of the overall market in 2018. The market is majorly driven by the increasing consumer inclination toward preventive healthcare. Vitamin D deficiency is a common issue in North America, which drives a large share of the market demand.
Besides, the increasing prevalence of low immunity disorders and chronic diseases propel the growth of the regional market excellently, leading to an increased focus on preventive health care. The US accounts for the largest share of the regional market, followed by Canada. The US market value is projected to reach USD 30,536.4 MN by 2025, registering 6.13% CAGR during the forecast period. Canada is projected to register 6.50% CAGR during the forecast period.
The European vitamin & mineral supplements market is emerging as a profitable market, globally. The feed supplement market pushes the market growth, consuming large amounts of vitamin & mineral supplements to meet the rising demand for poultry and swine products. Additionally, the increase in demand among consumers for protein intake drives the growth of the regional market. Moreover, the rising demand for nutritional products such as functional food boosts the regional market size.
Global Vitamin & Mineral Supplements Market – Competitive Analysis
Highly competitive, the vitamin & mineral supplements market appears fragmented due to the presence of many large and small players. Due to the low entry barriers, numbers of industry players are rising, increasing the market competition. Along with numerous international players, few regional players and new entrants, are also operating in the market.
New and online players are challenging many retailers and manufacturers. Many leading producers and retailers continue to expand through mergers & acquisitions and collaborations to gain a competitive share in the marketplace. The rapid proliferation of a wide range of products, primarily via online platforms, challenges these players.
Browse Full Report Details @ https://www.marketresearchfuture.com/reports/vitamin-mineral-supplements-market-8816
Major Players
Players leading the global vitamin & mineral Supplements market include Glanbia PLC (Ireland), The Nature's Bounty Co. (US), Herbalife Nutrition Ltd. (US), Amway Corp (US), Abbott Laboratories (US), Bayer AG (Germany), Otsuka Holdings Co. (Japan), GlaxoSmithKline plc (UK), Nu Skin Enterprises, Inc. (US), and Nature's Way Products, LLC (US), among others.
Industry Advancements/Related News
July 02, 2020 ---- Researchers at Friedman School of Nutrition Science and Policy at Tufts University (the US), stated that numbers of healthy people taking vitamin and mineral supplements are continually rising. Writing in the BMJ, the team says that the rise in taking dietary supplements attributes to the popularity of vitamins, minerals, and omega-3 to claims they can reduce the risk of non-communicable diseases. They point to randomized trial evidence that does not support the use of vitamin & mineral supplements to reduce the risk of these diseases, such as cardiovascular disease, cancer, or T2 diabetes.
NOTE: Our Team of Researchers are Studying Covid19 and its Impact on Various Industry Verticals and wherever required we will be considering Covid19 Footprints for Better Analysis of Market and Industries. Cordially get in Touch for More Details.
The global dietary supplements market size is expected to reach USD 239.46 Billion in 2028 and register a CAGR of 7.2% over the forecast period, according to the latest report by Reports and Data.
Major factors driving market revenue growth are rising prevalence of various chronic diseases such as diabetes, blood pressure, malnutrition, and cardiovascular diseases, increasing spending on healthy food, and growing awareness about tailor-made dietary supplements.Dietary supplements are used to add nutrients to the diet and improve the health status of an individual.
Some of the key functions of dietary supplements are energy and weight management, strengthen bone and joint, improve general health, gastrointestinal health, cardio health, immunity, and others.Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/929Dietary supplements are available in a variety of forms such as powders, gel capsules, capsules, tablets, and syrups.
Tablet segment accounted for major revenue share in the global market in 2020.
This can be attributed to increasing demand for multivitamins in tablet form due to low cost, dose accuracy, longer shelf life, easy to swallow, and others.
Increasing geriatric population and rising preference for healthy lifestyle are key factors boosting market revenue growth in this region.Major players in the market report include Amway, Herbalife Nutrition, ADM, Pfizer, Abbott Laboratories, Arkopharma Laboratories, Bayer, Nature’s Sunshine Products, FANCL, and Bionova Lifesciences.For the purpose of this report, Reports and Data has segmented the dietary supplements market based on type, function, mode of application, and region:Type Outlook (Revenue, USD Billion; 2018-2028)VitaminsMineralsAmino acidsBotanicalsEnzymesProbioticsFunction Outlook (Revenue, USD Billion; 2018-2028)AdditionalMedicinalSports NutritionMode of Application Outlook (Revenue, USD Billion; 2018-2028)CapsulesTabletsLiquidGel CapsulesLiquidPowderRegional Outlook (Revenue, USD Billion; 2018-2028)North America Europe Asia Pacific Latin America Middle East & Africa Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/929Some Key Highlights From the Report:In September 2021, Ambrosia-SupHerb announced their partnership with Tikun-Olam.
Market HighlightsGlobal Vitamin & Mineral Supplements Market is estimated to be valued at USD 1,08,148.1 Million by 2025, registering a CAGR of 6.70% during the forecast period.
Moreover, the expansion of the organized retail sector in developing economies offer growth opportunities for manufacturers.
However, the side effects associated with the overconsumption of these supplements are restraining the growth of the market.Asia-Pacific constituted a dominant share of the global vitamin & mineral supplements market in 2018.
The mineral segment is bifurcated into calcium, magnesium, iron, zinc, multi-minerals, and others.
The demand for blends has increased over the last few years mainly due to the multiple health benefits offered by the combination of two or more vitamins and minerals.
Moreover, the availability of vitamin and mineral blends is exceptionally high in both developed and developing economies.By end user, the market has been divided into men, women, and unisex.
OverviewThe global vitamin supplements market will grow at a CAGR of 6.65%during the forecast period 2018 to 2025.
As per vitamin supplements market analysts, the global market is anticipated to witness growth owing to the factors such as growing demand from the sports nutrition sector as well as increasing health issues and evolving diets .
However, the market for vitamin supplements will face challenges and restraints due to stringent government policies and difficulties in the production during the forecast period 2018 to 2025.Growing adoption of e-commerce in this market will support the growth.
Furthermore, companies using growth strategies to stay ahead in the global vitamin supplements industry are expected to help the market during the forecast period 2018 to 2025.
As this market report suggests that the market for vitamin supplements will register a CAGR of 6.65% and reach a US$30.52 billion by 2025, the market report highlights key areas vitamin supplements market-based companies need to focus on.
The vitamin supplements market research report highlights such key areas.The worldwide Vitamin Supplements Market and the cream market are profoundly divided, with various domestic players existing with solid conveyance organizations and global food accreditations.
Global Antibiotics Market Research Report: By Drug class (Cephalosporins, Penicillin, Macrolides, Carbapenem, Aminoglycosides, Sulfonamides, Others), By Spectrum of Activity (Broad-spectrum Antibiotic, Narrow-spectrum Antibiotic), By Drug Origin (Natural, Semi-synthetic, Synthetic) and By End-User (Hospitals & Clinics, Research Organizations, Others) – Forecast to 2025Market Highlights:According to MRFR analysis, Antibiotics Market is expected to register a CAGR of 4.8% during the forecast period of 2019 to 2025 and was valued at USD 51,835 Million in 2018.Antibiotics are powerful medicines that fight bacterial infections.
Several types of antibiotics are available, and they are generally available with a prescription in most countries.The growth of global antibiotics market is driven by various factors such as increasing efforts undertaken by major companies for the development of advanced antibiotic products, development of generic drugs, increasing approval of antibiotic drugs, rise in incidence of chronic and infectious diseases, growing investment opportunities by biotech companies in research and development, is expected to drive the growth of the global antibiotics market.Several market players currently dominate the global antibiotics market.
The carbapenem segment is likely to be the fastest growing during the review period due to the increasing incidence of pneumonia, urinary tract infections, which would increase the usage of the carbapenem class of antibiotics.
The broad-spectrum antibiotic segment is expected to hold the majority share of the market as this broad-spectrum antibiotic act against a wide range of diseases, which helps to fight against microbial resistance.The global antibiotics market has been segmented based on drug origin into natural, semisynthetic, and synthetic.
Semisynthetic is expected to be the fastest segment owing to fewer side-effects and has a higher spectrum of activity, which would eventually drive the growth of the antibiotic market in this segment.The global antibiotics market has been segmented based on drug origin into natural, synthetic, and semisynthetic.The end user segment of the antibiotics market includes hospitals & clinics, research organizations, and others.
For instance, according to centers for disease control and prevention (CDC), in 2018, use of the most antibiotics in hospitals increased by nearly 40% for carbapenems and more than 30% for vancomycin.
According to the new market research report “Therapeutic Drug Monitoring Market by Product (Equipment (Immunoassay Analyzers), Consumables), Technology (Immunoassays, Chromatography-MS), Class of Drugs (Antibiotic Drugs, Bronchodilator Drugs), End User – Global Forecast to 2025″, published by MarketsandMarkets™, the Therapeutic Drug Monitoring Market is projected to reach USD 2.0 billion by 2025 from USD 1.4 billion in 2020, at a CAGR of 6.9% from 2020 to 2025.Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=155350443The TDM Market growth is largely driven by factors such as the rising number of organ transplant procedures, the use of TDM across various therapeutic fields, the increasing preference for precision medicine, a growing focus on R related to TDM, and technological advancements in immunoassay instruments.
Increasing adoption in the treatment of autoimmune diseases is expected to provide a wide range of growth opportunities for players in the market.Consumables is expected to hold the largest share of the therapeutic drug monitoring market in 2020On the basis of product, the market is segmented into equipment and consumables.
In 2019, consumables segment accounted for the largest market share, primarily due to the repeat purchases of kits and reagents and the increasing number of immunoassay tests being performed across the globe.Browse in-depth TOC on “Therapeutic Drug Monitoring Market“288 – Tables35 – Figures241 – PagesImmunoassays is expected to hold the largest share of the market in 2020Based on technology, the TDM Market is segmented into immunoassays and chromatography-MS.
In 2019, immunoassays segment accounted for the largest market share, due to the increasing incidence of chronic and infectious diseases and technological innovation.Antiepileptic drugs is expected to hold the largest share of the therapeutic drug monitoring market in 2020On the basis of class of drug, the market is segmented into antiepileptic drugs, antibiotic drugs, immunosuppressant drugs, antiarrhythmic drugs, bronchodilator drugs, psychoactive agents, and other drugs.
During 2019, antiepileptic drugs held the largest share among the class of drug due to the high complexity and heterogeneity of epilepsy, lack of biological markers or specific clinical signs aside from the frequency of seizures to assess treatment efficacy or toxicity, and the highly complex pharmacokinetics of these drugs.Hospital laboratories segment commanded the largest share of the TDM Market in 2019By end user, the market is segmented into hospital laboratories, commercial & private laboratories, and other end users.
Hospital laboratories accounted for the largest share of the market in 2019.
Global Biosensors Market: Information by Technology (Electrochemical, Optical, Thermal, Piezoelectric Biosensors), by Application (Medical Testing, Food Toxicity, Industrial Process, Environmental and Agricultural Testing), by End User (Point-of-Care, Home Diagnostics, Research Laboratories, Food Industry, and Security & Biodefense), and by Region (North America, Europe, Asia-Pacific, Rest of the World)—Forecast till 2027Market Research Future has released its extensive report on the global biosensor market which reveals a CAGR of 9.6% during the assessment period of 2014 to 2020.
Growing use of point-of-care testing (POCT) is another key factor driving the demand for biosensors as they are vital in furthering this type of healthcare facility.
Based on technology, the market is segmented into piezoelectric biosensors, thermal biosensors, electrochemical biosensors, optical biosensors, and others.
The electrochemical biosensor market represents the largest share of the biosensor market.On the basis of end-user, the market is segmented to represent home diagnostics, the point of care, research laboratories, food industry, biodefence & security, and others.
The security & biodefense segment is the most significant segment in the biosensors market due to increasing biological threats and the need to protect against them.By application, the market is categorized into an industrial process, food toxicity, medical testing, agricultural testing, environmental market, and others.Global segmentation of the biosensor market divides it into North America, Europe, Asia-Pacific, and the Rest of the World.Regional AnalysisNorth America accounts for the largest share of the global market and is led by the U.S which is the most prominent country in the region.
The presence of several leading market players and a growing diabetic population is expected to increase the demand for biosensors.
